ChemoCentryx (CCXI) Competitor Comparison
We are evaluating the key criteria listed to compare ChemoCentryx (CCXI) against its competitors in the Biotechnology industry.
Market Capitalization
52 / 368Gross Profits
199 / 278Total Revenue
137 / 300EBITDA
231 / 337Free Cashflow
226 / 352Quick Ratio
198 / 357Earnings per Share
126 / 359Dividend yield
0 / 6Total Cash
100 / 358Performance 3 years
11 / 368Performance 5 years
15 / 368Performance 10 years
25 / 368Linearity 3 years
327 / 368Linearity 5 years
338 / 368Linearity 10 years
343 / 368Total Rank
303 / 368Dividend Rank
87 / 368Valuation Rank
327 / 368Piotroski Rank
268 / 368Muliplier Rank
312 / 368Performance 10 years - CCXI ranking 25 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.